Erythropoiesis Stimulating Agent Administration Improves Survival After Severe Traumatic Brain Injury: A Matched Case Control Study

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annals of Surgery

• Publication date

  2010-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SLA.0b013e3181b844faPMID 19779323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin as a neuroprotective agent in traumatic brain injury Review.

  2009cited by this paper
• A Phase I/II Trial of High-Dose Erythropoietin in Extremely Low Birth Weight Infants: Pharmacokinetics and Safety

  2009cited by this paper
• A Phase I/II Trial of High-Dose Erythropoietin in Extremely Low Birth Weight Infants: Pharmacokinetics and Safety

  2008cited by this paper
• The non‐haematopoietic biological effects of erythropoietin

  2008cited by this paper
• Improved survival of critically ill trauma patients treated with recombinant human erythropoietin.

  2008cited by this paper
• Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice.

  2008cited by this paper
• Role of anemia in traumatic brain injury.

  2008cited by this paper
• Evidence‐based management of anaemia in severely injured patients

  2008cited by this paper
• An Approach to Using Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants

  2008cited by this paper
• Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.

  2007cited by this paper
• Role of erythropoietin in the brain.

  2007cited by this paper
• Efficacy and safety of epoetin alfa in critically ill patients.

  2007cited by this paper
• Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.

  2007cited by this paper
• Post‐ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia

  2007cited by this paper
• Erythropoietin Protects from Post-Traumatic Edema in the Rat Brain

  2007cited by this paper
• Guidelines for the management of severe traumatic brain injury. I. Blood pressure and oxygenation.

  2007cited by this paper
• Neuroprotection by erythropoietin administration after experimental traumatic brain injury.

  2007cited by this paper
• Erythropoietin, a Cytoprotective and Regenerative Cytokine, and the Hypoxic Brain

  2006cited by this paper
• The Brain Erythropoietin System and its Potential for Therapeutic Exploitation in Brain Disease

  2006cited by this paper
• New avenues of exploration for erythropoietin.

  2005cited by this paper
• Science review: Recombinant human erythropoietin in critical illness: a role beyond anemia?

  2004cited by this paper
• Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial

  2002cited by this paper
• Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage

  2002cited by this paper
• Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

  2000cited by this paper

• Efficacy and safety of erythropoietin in traumatic brain injury: a meta-analysis of RCTs and observational studies

  2026cites this paper
• Emerging therapies for immunomodulation in traumatic brain injury: A systematic review and meta-analysis

  2024influential citation
• Prediction of prognosis in patients with cerebral contusions based on machine learning

  2024cites this paper
• Neuroprotective effect of Erythropoietin in experimental spinal cord ischemia-reperfusion injury

  2024cites this paper
• Transcriptomic and bioinformatics analysis of the mechanism by which erythropoietin promotes recovery from traumatic brain injury in mice

  2023cites this paper
• Decent Work, Work Motivation, Work Engagement and Burnout in Physicians

  2020cites this paper
• Erythropoietin Therapy in Critically Ill and Acute Kidney Injury Patients

  2019cites this paper
• Use of Neuroprotective agents for Traumatic Brain Injury

  2019cites this paper
• Controversies in Severe Traumatic Brain Injury Management

  2018cites this paper
• Erythropoietin and Its Derivatives: Mechanisms of Neuroprotection and Challenges in Clinical Translation

  2017cites this paper
• Therapeutic effect of erythropoietin in patients with traumatic brain injury: a meta-analysis of randomized controlled trials.

  2017cites this paper
• Erythropoiesis-Stimulating Agent Administration and Survival After Severe Traumatic Brain Injury

  2017cites this paper
• Effects of erythropoietin on neurological performance of patients with traumatic brain injury: a systematic literature review

  2017cites this paper
• Harms of off-label erythropoiesis-stimulating agents for critically ill people.

  2017cites this paper
• Anemia management after acute brain injury

  2016cites this paper
• Effects of erythropoietin on neurological performance of patients with traumatic brain injury : A systematic review of the literatures

  2016cites this paper
• Therapies negating neuroinflammation after brain trauma.

  2016cites this paper
• Erythropoietin for Traumatic Brain Injury: A Systematic Review and Meta-Analysis

  2016cites this paper
• Transfusion strategies in patients with traumatic brain injury: which is the optimal hemoglobin target?

  2016cites this paper
• Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: A randomized, double blind and controlled clinical trial.

  2016cites this paper
• The effects of anaemia and transfusion on patients with traumatic brain injury: A review

  2016cites this paper
• Anemia and iron-restricted erythropoiesis in traumatic critical illness

  2016cites this paper
• The Negative Impact of Anemia in Outcome from Traumatic Brain Injury.

  2016cites this paper
• Diffuse Axonal Injury

  2016cites this paper
• Recent developments in clinical trials for the treatment of traumatic brain injury.

  2015influential citation
• Functional EpoR Pathway Utilization Is Not Detected in Primary Tumor Cells Isolated from Human Breast, Non-Small Cell Lung, Colorectal, and Ovarian Tumor Tissues

  2015cites this paper
• General intensive care for patients with traumatic brain injury: An update

  2014cites this paper
• Update in the management of severe traUmatic brain injUry

  2014cites this paper
• Erythropoietin for traumatic brain injury--reply.

  2014cites this paper
• Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial.

  2014cites this paper
• Impact of Erythropoietin on Intensive Care Unit Patients

  2013cites this paper
• Erythropoietin and cytoprotective cytokines in experimental traumatic brain injury.

  2013cites this paper
• Erythropoietin neuroprotection with traumatic brain injury.

  2013cites this paper
• Peptidergic drugs for the treatment of traumatic brain injury

  2013cites this paper
• Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting.

  2013cites this paper
• Haemoglobin management in acute brain injury

  2013cites this paper
• What is the Role of Erythropoietin in Acute Myocardial Infarct? Bridging the Gap Between Experimental Models and Clinical Trials

  2013cites this paper
• Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis

  2013influential citation
• Neuro-Protection after Traumatic Brain Injury: Novel Strategies.

  2013cites this paper
• Protective effects of erythropoietin on astrocytic swelling after oxygen-glucose deprivation and reoxygenation: mediation through AQP4 expression and MAPK pathway.

  2013cites this paper
• Emerging pharmacological agents to improve survival from traumatic brain injury

  2013influential citation
• Protective effect of erythropoietin on spinal ischemia-reperfusion injury

  2012cites this paper
• Red Blood Cell Transfusion and Transfusion Alternatives in Traumatic Brain Injury

  2012cites this paper
• The effect of erythropoietin on normal and neoplastic cells

  2012cites this paper
• Implication of Oxidative Stress and “Labile Iron” in the Molecular Mechanisms of Ischemic Stroke

  2012cites this paper
• Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study.

  2012cites this paper
• The use of erythropoiesis-stimulating agents in the intensive care unit.

  2012cites this paper
• Management of Acute Traumatic Brain Injury

  2012cites this paper
• Matched case-control studies: a review of reported statistical methodology

  2012cites this paper
• Erythropoietin: still on the neuroprotection road

  2012cites this paper
• Identification and validation of target pathways influencing outcome after traumatic brain injury

  2012cites this paper
• Economic analysis of epoetin alfa in critically ill trauma patients

  2012cites this paper
• Attenuation of spinal cord ischemia and reperfusion injury by erythropoietin.

  2011cites this paper
• Success in sentinel lymph node procedures in obese patients with breast cancer.

  2010cites this paper
• Aktuelle Ergebnisse notfallmedizinischer Forschung 2009/2010

  2010cites this paper
• Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?

  2010cites this paper
• Erythropoiesis and the mystery of an unexplained survival benefit.

  2010cites this paper